All lobbying filings

The Petrizzo Group, Inc.

The Petrizzo Group, Inc. filed a Q2 report for Akebia Therapeutics, Inc. on July 13, 2026, reporting $60,000 in lobbying income.

Lobbying for Akebia Therapeutics, Inc. · Fully integrated biopharmaceutical company addressing complications of kidney disease.

As filed: THE PETRIZZO GROUP, INC. for AKEBIA THERAPEUTICS, INC.

All filings by The Petrizzo Group, Inc. · Everything Akebia Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 13, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Provided legislative advocacy specific to the payment of innovative drugs, such as phosphate binders and anemia management drugs in the Medicare End-Stage Renal Dialysis Prospective Payment System (ESRD PPS).

Medicare/Medicaid

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.